Stay updated on Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.

Latest updates to the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page
- CheckyesterdayChange DetectedUPMC Hillman Cancer Center was added as a participating site for the study. University of Pittsburgh Cancer Institute (UPCI) was removed.SummaryDifference0.2%

- Check9 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4. This update reflects a new page template/version used for the study page, without altering its content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision tag was updated to v3.6.3, indicating a minor update to the page version without changing study information.SummaryDifference0.0%

- Check37 days agoChange DetectedThe page shows an updated revision tag from v3.6.0 to v3.6.2, indicating a small version update to the page. This update does not modify the study content or eligibility.SummaryDifference0.0%

- Check51 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating the study is not seeking enrollees. New help and navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was updated, and the page shows a revision label (Revision: v3.6.0).SummaryDifference0.3%

- Check59 days agoChange DetectedThe page shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a maintenance update to the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab and SRS in Recurrent Meningioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and SRS in Recurrent Meningioma Clinical Trial page.